vs

Side-by-side financial comparison of Ensysce Biosciences, Inc. (ENSC) and Medalist Diversified REIT, Inc. (MDRR). Click either name above to swap in a different company.

Medalist Diversified REIT, Inc. is the larger business by last-quarter revenue ($2.8M vs $1.9M, roughly 1.5× Ensysce Biosciences, Inc.). Medalist Diversified REIT, Inc. runs the higher net margin — -18.8% vs -147.0%, a 128.3% gap on every dollar of revenue. On growth, Ensysce Biosciences, Inc. posted the faster year-over-year revenue change (44.4% vs 11.8%). Over the past eight quarters, Ensysce Biosciences, Inc.'s revenue compounded faster (107.9% CAGR vs 4.8%).

Ensysce Biosciences, Inc. is a clinical-stage biotechnology firm specializing in developing innovative prodrug therapies for pain management and oncology indications. Its proprietary platform is designed to reduce opioid abuse risks while enhancing treatment efficacy, targeting global healthcare and pharmaceutical markets with a focus on unmet clinical needs.

Medalist Diversified REIT, Inc. is a publicly traded real estate investment trust focused on owning, operating, and acquiring income-generating multi-family residential properties. Its portfolio is concentrated in high-growth US Southeast and Mid-Atlantic markets, targeting stable long-term returns for shareholders via rental income and property appreciation.

ENSC vs MDRR — Head-to-Head

Bigger by revenue
MDRR
MDRR
1.5× larger
MDRR
$2.8M
$1.9M
ENSC
Growing faster (revenue YoY)
ENSC
ENSC
+32.6% gap
ENSC
44.4%
11.8%
MDRR
Higher net margin
MDRR
MDRR
128.3% more per $
MDRR
-18.8%
-147.0%
ENSC
Faster 2-yr revenue CAGR
ENSC
ENSC
Annualised
ENSC
107.9%
4.8%
MDRR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ENSC
ENSC
MDRR
MDRR
Revenue
$1.9M
$2.8M
Net Profit
$-2.8M
$-529.6K
Gross Margin
Operating Margin
-147.8%
14.8%
Net Margin
-147.0%
-18.8%
Revenue YoY
44.4%
11.8%
Net Profit YoY
22.3%
-88.4%
EPS (diluted)
$-0.51
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENSC
ENSC
MDRR
MDRR
Q4 25
$1.9M
$2.8M
Q3 25
$493.1K
$2.8M
Q2 25
$1.4M
$2.5M
Q1 25
$1.3M
$2.3M
Q4 24
$1.3M
$2.5M
Q3 24
$3.4M
$2.3M
Q2 24
$2.3M
Q1 24
$2.6M
Net Profit
ENSC
ENSC
MDRR
MDRR
Q4 25
$-2.8M
$-529.6K
Q3 25
$-3.7M
$-395.9K
Q2 25
$-1.7M
$-456.4K
Q1 25
$-1.9M
$-1.0M
Q4 24
$-3.6M
$-281.2K
Q3 24
$661.8K
$-527.0K
Q2 24
$-521.7K
Q1 24
$1.4M
Operating Margin
ENSC
ENSC
MDRR
MDRR
Q4 25
-147.8%
14.8%
Q3 25
-758.7%
15.8%
Q2 25
-127.6%
9.8%
Q1 25
-149.1%
-23.8%
Q4 24
-274.3%
17.7%
Q3 24
18.9%
13.0%
Q2 24
9.4%
Q1 24
Net Margin
ENSC
ENSC
MDRR
MDRR
Q4 25
-147.0%
-18.8%
Q3 25
-756.3%
-14.2%
Q2 25
-126.4%
-18.5%
Q1 25
-147.4%
-43.4%
Q4 24
-273.4%
-11.1%
Q3 24
19.4%
-22.6%
Q2 24
-22.7%
Q1 24
52.8%
EPS (diluted)
ENSC
ENSC
MDRR
MDRR
Q4 25
$-0.51
$-0.49
Q3 25
$-1.29
$-0.33
Q2 25
$-0.79
$-0.34
Q1 25
$-1.39
$-0.74
Q4 24
$-0.89
$-0.24
Q3 24
$1.00
$-0.47
Q2 24
$-0.47
Q1 24
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENSC
ENSC
MDRR
MDRR
Cash + ST InvestmentsLiquidity on hand
$4.3M
$2.6M
Total DebtLower is stronger
$51.4M
Stockholders' EquityBook value
$3.2M
$9.4M
Total Assets
$7.5M
$77.7M
Debt / EquityLower = less leverage
5.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENSC
ENSC
MDRR
MDRR
Q4 25
$4.3M
$2.6M
Q3 25
$1.7M
$1.9M
Q2 25
$2.2M
$2.0M
Q1 25
$3.1M
$2.7M
Q4 24
$3.5M
$4.8M
Q3 24
$4.2M
$3.1M
Q2 24
$3.8M
Q1 24
$3.6M
Total Debt
ENSC
ENSC
MDRR
MDRR
Q4 25
$51.4M
Q3 25
$63.6M
Q2 25
$49.6M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ENSC
ENSC
MDRR
MDRR
Q4 25
$3.2M
$9.4M
Q3 25
$1.2M
$10.4M
Q2 25
$3.4M
$13.4M
Q1 25
$3.0M
$14.0M
Q4 24
$3.7M
$15.0M
Q3 24
$6.9M
$12.6M
Q2 24
$13.2M
Q1 24
$13.7M
Total Assets
ENSC
ENSC
MDRR
MDRR
Q4 25
$7.5M
$77.7M
Q3 25
$3.2M
$92.1M
Q2 25
$5.6M
$77.7M
Q1 25
$4.6M
$78.2M
Q4 24
$5.6M
$75.1M
Q3 24
$9.4M
$74.6M
Q2 24
$75.2M
Q1 24
$76.0M
Debt / Equity
ENSC
ENSC
MDRR
MDRR
Q4 25
5.45×
Q3 25
6.13×
Q2 25
3.70×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENSC
ENSC
MDRR
MDRR
Operating Cash FlowLast quarter
$-1.5M
$1.5M
Free Cash FlowOCF − Capex
$77.0K
FCF MarginFCF / Revenue
2.7%
Capex IntensityCapex / Revenue
51.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENSC
ENSC
MDRR
MDRR
Q4 25
$-1.5M
$1.5M
Q3 25
$-1.9M
$1.6M
Q2 25
$-2.7M
$244.1K
Q1 25
$-1.7M
$460.0K
Q4 24
$-764.1K
$1.8M
Q3 24
$-1.0M
$139.9K
Q2 24
$778.6K
Q1 24
$492.4K
Free Cash Flow
ENSC
ENSC
MDRR
MDRR
Q4 25
$77.0K
Q3 25
$1000.0K
Q2 25
$-181.5K
Q1 25
$322.4K
Q4 24
$893.7K
Q3 24
$-164.7K
Q2 24
$645.6K
Q1 24
$265.8K
FCF Margin
ENSC
ENSC
MDRR
MDRR
Q4 25
2.7%
Q3 25
35.9%
Q2 25
-7.4%
Q1 25
13.9%
Q4 24
35.4%
Q3 24
-7.0%
Q2 24
28.1%
Q1 24
10.3%
Capex Intensity
ENSC
ENSC
MDRR
MDRR
Q4 25
51.5%
Q3 25
20.4%
Q2 25
17.3%
Q1 25
5.9%
Q4 24
35.7%
Q3 24
13.0%
Q2 24
5.8%
Q1 24
8.8%
Cash Conversion
ENSC
ENSC
MDRR
MDRR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-1.54×
Q2 24
Q1 24
0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENSC
ENSC

Segment breakdown not available.

MDRR
MDRR

Retail Center Properties$1.6M58%
Other$1.2M42%

Related Comparisons